These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21299695)

  • 1. Chronic hepatitis B surveillance in Victoria, 1998-2008: instituting a 21st century approach to an old disease.
    Williams S; Vally H; Fielding J; Cowie B
    Aust N Z J Public Health; 2011 Feb; 35(1):16-21. PubMed ID: 21299695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health management of perinatal hepatitis B virus.
    Libbus MK; Phillips LM
    Public Health Nurs; 2009; 26(4):353-61. PubMed ID: 19573214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of and risk factors for hepatitis B and C infection among Mongolian blood donors.
    Tserenpuntsag B; Nelson K; Lamjav O; Triner W; Smith P; Kacica M; McNutt LA
    Transfusion; 2010 Jan; 50(1):92-9. PubMed ID: 19788639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A validation of the use of names to screen for risk of chronic hepatitis B in Victoria, Australia, 2001 to 2010.
    MacLachlan JH; Wang YJ; Cowie BC
    Euro Surveill; 2013 Nov; 18(47):. PubMed ID: 24300885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy.
    Thornley S; Bullen C; Roberts M
    J Theor Biol; 2008 Oct; 254(3):599-603. PubMed ID: 18644385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia.
    El Beltagy KE; Al Balawi IA; Almuneef M; Memish ZA
    Int J Infect Dis; 2008 Sep; 12(5):495-9. PubMed ID: 18400539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of chronic hepatitis B in South Western Sydney: evaluation of the country of birth method using maternal seroprevalence data.
    Turnour CE; Cretikos MA; Conaty SJ
    Aust N Z J Public Health; 2011 Feb; 35(1):22-6. PubMed ID: 21299696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East.
    Specialist Panel on Chronic Hepatitis B in the Middle East
    J Viral Hepat; 2012 Jan; 19(1):9-22. PubMed ID: 22187943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic hepatitis B--still a problem in children].
    Pohaci-Antonesei L; Bratu L; Rusu T; Moraru E
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):738-42. PubMed ID: 21243800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of acute hepatitis C infection surveillance --- United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(43):1407-10. PubMed ID: 21048562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic approach to chronic hepatitis B and C in the dawn of the third millenium].
    Adler M; Bourgeois N
    Rev Med Brux; 2001 Jun; 22(3):141-51. PubMed ID: 11488081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005.
    Cowie B; Karapanagiotidis T; Enriquez A; Kelly H
    Aust N Z J Public Health; 2010 Feb; 34(1):72-8. PubMed ID: 20920109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007.
    Spradling PR; Richardson JT; Buchacz K; Moorman AC; Brooks JT;
    J Viral Hepat; 2010 Dec; 17(12):879-86. PubMed ID: 20158604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a surveillance system to identify and treat newly acquired hepatitis C infection.
    Walsh N; Lim M; Hellard M
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1891-4. PubMed ID: 19120877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of chronic hepatitis B and C in Victoria, Australia: insights and impacts from enhanced surveillance.
    MacLachlan JH; Romero N; Higgins N; Coutts R; Chan R; Stephens N; Cowie BC
    Aust N Z J Public Health; 2020 Feb; 44(1):59-64. PubMed ID: 31535439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients.
    Bell SJ; Lau A; Thompson A; Watson KJ; Demediuk B; Shaw G; Chen RY; Ayres A; Yuen L; Bartholomeusz A; Locarnini SA; Desmond PV
    J Clin Virol; 2005 Feb; 32(2):122-7. PubMed ID: 15653414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis B in Poland in 2008].
    Stepień M; Czarkowski MP
    Przegl Epidemiol; 2010; 64(2):239-44. PubMed ID: 20731229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case definitions for diseases under national surveillance.
    Can Commun Dis Rep; 2000 May; 26 Suppl 3():i-iv 1-122. PubMed ID: 11055080
    [No Abstract]   [Full Text] [Related]  

  • 19. Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece.
    Stefos A; Gatselis N; Zachou K; Rigopoulou E; Hadjichristodoulou C; Dalekos GN
    Eur J Intern Med; 2009 Jan; 20(1):35-43. PubMed ID: 19237090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A in Australia in the 1990s: future directions in surveillance and control.
    Amin J; Heath T; Morrell S
    Commun Dis Intell; 1999 May; 23(5):113-20. PubMed ID: 10429311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.